Article info
Basic and translational research
Extended report
Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis
- Correspondence to Professor Roswitha Sgonc, Division of Experimental Pathophysiology and Immunology, Biocenter, Medical University of Innsbruck, Innrain 80-82, Innsbruck 6020, Austria; roswitha.sgonc{at}i-med.ac.at
Citation
Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis
Publication history
- Received March 4, 2015
- Revised July 1, 2015
- Accepted August 1, 2015
- First published September 11, 2015.
Online issue publication
April 10, 2023
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
- Data supplement 2 - Online figures
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/